On October 3, 2024, Haleon plc completed the off-market purchase of 60,526,315 ordinary shares from Pfizer for £230 million, cancelling 30,161,278 shares and holding 30,365,037 as treasury shares, resulting in 9,053,360,882 shares with voting rights.